本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Annexon, Inc.

1.68
+0.220015.07%
盘后1.680.00000.00%19:59 EDT
成交量:360.49万
成交额:596.09万
市值:1.84亿
市盈率:-1.67
高:1.77
开:1.42
低:1.40
收:1.46
数据加载中...

公司资料

公司名字:
Annexon, Inc.
交易所:
NASDAQ
成立时间:
2011
员工人数:
100
公司地址:
1400 Sierra Point Parkway,Building C,Suite 200,Brisbane,California,United States
邮编:
94005
电话:
传真:
650 636 9773
简介:
Annexon, Inc.于2011年3月3日根据特拉华州法律注册成立。该公司是一家临床阶段生物制药公司,致力于开发针对经典补体介导的身体,大脑和眼睛疾病的新型疗法。

董事

名称
职位
Douglas Love
President, Chief Executive Officer and Director
William D. Young
Chairman and Director
Carol Gallagher
Director
Emmett Cunningham
Director
Jung Choi
Director
Muneer A. Satter
Director
Ricky Sun
Director
Thomas G. Wiggans
Director

股东

名称
职位
Douglas Love
President, Chief Executive Officer and Director
Jennifer Lew
Executive Vice President and Chief Financial Officer
Michael Overdorf
Executive Vice President and Chief Business Officer
Sanjay Keswani
Executive Vice President and Chief Medical Officer
Ted Yednock
Executive Vice President and Chief Scientific Officer